Our current study demonstrated that over-expression of TGF-β mRNA in PBMCs from patients at baseline was positively associated with a higher percentage of Treg cells, the increase of which was related to the patient’s immune tolerance and tumor immune escape. The gene discussed is TGFB1; the disease is neoplasm.